Literature DB >> 26262046

Lead User Design: Medication Management in Electronic Medical Records.

Morgan Price1, Jens H Weber1, Iryna Davies2, Paule Bellwood2.   

Abstract

Improvements in medication management may lead to a reduction of preventable errors. Usability and user experience issues are common and related to achieving benefits of Electronic Medical Records (EMRs). This paper reports on a novel study that combines the lead user method with a safety engineering review to discover an innovative design for the medication management module in EMRs in primary care. Eight lead users were recruited that represented prescribers and clinical pharmacists with expertise in EMR design, evidence-based medicine, medication safety and medication research. Eight separate medication management module designs were prototyped and validated, one with each lead user. A parallel safety review of medicaiton management was completed. The findings were synthesized into a single common set of goals, activities and one interactive, visual prototype. The lead user method with safety review proved to be an effective way to elicit diverse user goals and synthesize them into a common design. The resulting design ideas focus on meeting the goals of quality, efficiency, safety, reducing the cognitive load on the user, and improving communication wih the patient and the care team. Design ideas are being adapted to an existing EMR product, providing areas for further work.

Entities:  

Mesh:

Year:  2015        PMID: 26262046

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  2 in total

1.  Applying STOPP Guidelines in Primary Care Through Electronic Medical Record Decision Support: Randomized Control Trial Highlighting the Importance of Data Quality.

Authors:  Morgan Price; Iryna Davies; Raymond Rusk; Mary Lesperance; Jens Weber
Journal:  JMIR Med Inform       Date:  2017-06-15

2.  Recent perspectives of electronic medical record systems.

Authors:  Xiao-Ying Zhang; Peiying Zhang
Journal:  Exp Ther Med       Date:  2016-04-06       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.